EnzySurge Ltd., a Richmond, VA-based provider of innovative solutions for advanced chronic wound management, completed a $2.5m round of funding.
The round, which brought the total amount that the company has raised to date to $10m, was led by Eli Gilboa, CPA, of Gilboa & Licht, who serves as the company’s active chairman.
The new funds will enable the company to accelerate its sales and marketing efforts in the US during the first half of 2010.
EnzySurge recently received clearance from the U.S. Food and Drug Administration (FDA) to market SilverStream(TM), a new solution for use under the supervision of a healthcare professional for management and moisturizing of wounds such as stage I-IV pressure ulcers, stasis ulcers, diabetic foot ulcers, post-surgical wounds, first and second degree burns, cuts abrasions and minor skin irritations.
FinSMEs
22/12/2009